John B. Robbins
Affiliations: |
Google:
"John Robbins"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Srinivasa-Gopalan Sampathkumar | post-doc | 2000-2003 | National Institutes of Health - NICHD |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Passwell JH, Ashkenazi S, Banet-Levi Y, et al. (2019) Erratum to 'Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children' [Vaccine 28 (2010) 2231-2235]. Vaccine |
| Farzam N, Ramon-Saraf R, Banet-Levi Y, et al. (2017) Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice. Vaccine |
| Robbins JB, Schneerson R, Kubler-Kielb J, et al. (2014) Toward a new vaccine for pertussis. Proceedings of the National Academy of Sciences of the United States of America. 111: 3213-6 |
| Thierry-Carstensen B, Dalby T, Stevner MA, et al. (2013) Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine. 31: 5178-91 |
| Keitel WA, Dai Z, Awe RW, et al. (2013) Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen. Bmc Infectious Diseases. 13: 276 |
| Szu SC, Hunt S, Xie G, et al. (2013) A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned. Vaccine. 31: 1970-4 |
| Pozsgay V, Kubler-Kielb J, Coxon B, et al. (2012) Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigens. The Journal of Organic Chemistry. 77: 5922-41 |
| Schmidt DS, Bieging KT, Gomez-de-León P, et al. (2012) Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera. The Pediatric Infectious Disease Journal. 31: 876-8 |
| Bellanti JA, Lin FY, Chu C, et al. (2012) Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis. Clinical and Vaccine Immunology : Cvi. 19: 140-5 |
| Robbins JB, Schneerson R, Xie G, et al. (2011) Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proceedings of the National Academy of Sciences of the United States of America. 108: 17871-5 |